The global, regional, and national burden of early, middle, and late-onset esophageal cancer and trends from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021
Authors:
- Zongyuan LiZLZongyuan Li
- Jili LiJLJili Li
- Cheng YuCYCheng Yu
- Jianqi HaoJHJianqi Hao
- Jiantong SunJSJiantong Sun
- Yi ChenYCYi Chen
- Jian ZhangJZJian Zhang
- Kejia ZhaoKZKejia Zhao
- Feng LinFLFeng Lin
Open Access
- 1 October 2025
- journal article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 8477-8496
Abstract
Background: Although the overall burden has gradually decreased, our understanding of the differences in disease burden across various age groups remains incomplete and controversial. This study aimed to provide an updated estimate of the esophageal cancer burden, with a focus on temporal trends and age-specific patterns. Methods: We extracted data from the Global Burden of Disease Study (GBD) 2021. Esophageal cancer was grouped into three groups: early-onset (EOEC, 15–49 years), middle-onset (MOEC, 50–69 years), and late-onset esophageal cancer (LOEC, ≥70 years). Age-standardized rates (ASRs) ensured the comparability of age-standardized incidence rate (ASIR), mortality rate (ASMR), and disability-adjusted life-years (DALYs) rate (ASDR). Joinpoint regression identified temporal trends, and average annual percent change (AAPC) with 95% confidence intervals (CIs) was calculated. Furthermore, we conducted frontier, decomposition, cross-country inequality, and risk factor analyses. Bayesian age-period-cohort (BAPC) model was utilized to forecast future epidemiological trajectories from 2022 to 2035. Results: Globally, although the ASIR of EOEC declined from 1.95 per 100,000 in 1990 to 1.08 in 2021 with an AAPC of −1.9 (95% CI: −2.05 to −1.74, PConclusions: Our findings highlighted the need for targeted cancer control strategies that address population-specific needs, particularly with respect to age, gender, and sociodemographic disparities.Keywords
This publication has 51 references indexed in Scilit:
- Early-Onset Esophageal Adenocarcinoma Presents With Advanced-Stage Disease But Has Improved Survival Compared With Older IndividualsGastroenterology, 2020
- Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival TimesClinical Gastroenterology and Hepatology, 2019
- Dental fluorosis and oral health in the African Esophageal Cancer Corridor: Findings from the Kenya ESCCAPE case–control study and a pan‐African perspectiveInternational Journal of Cancer, 2018
- The African Esophageal Cancer Consortium: A Call to ActionJournal of Global Oncology, 2018
- Projecting the future burden of cancer: Bayesian age–period–cohort analysis with integrated nested Laplace approximationsBiometrical Journal, 2017
- Menopausal hormone therapy and the risk of esophageal and gastric cancerInternational Journal of Cancer, 2017
- Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statementThe Lancet, 2016
- Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysisDiseases of the Esophagus, 2015
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000
- The surveillance, epidemiology, and end results program: a national resource.1999